Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
33:50
|
Download MP3
Related Videos
33:51
Ep. 259 - Causal Biology and Big Data, Ultra-Rare Drugs at FDA
39:34
Ep. 32 - Galapagos' Paul Stoffels
7:30
Managing pivots by analyzing trends and extracting insights
35:24
Ep. 68 - Inside BeiGene: CEO John Oyler on Owning the Drug Development Process
26:58
Ep. 256 - ESMO Recap: Keeping TIGIT Alive, Rybrevant & Immunotherapy Anniversary
32:03
Ep. 40 - Flagship's Noubar Afeyan
31:31
Understanding the competitive landscape for specific drug modalities or targets
0:42
BioCentury-BayHelix 11th China Healthcare Summit
0:37
Pharmas’ pandemic collaboration can and must continue: Plump on The BioCentury Show
34:40
Ep. 254 - Takeaways from Grand Rounds 2024
21:50
Ep. 255 - Pediatric PRVs, Biosecure & Novo's Obesity Miss
34:19
Ep. 31 - DiMe's Jennifer Goldsack
1:20
Finding in- or out-licensing opportunities with BioCentury's BCIQ database
2:26
The BioCentury Show: The Best of 2023
0:43
10th BioCentury-BayHelix China Healthcare Summit
0:45
Making Galapagos fit for survival: Stoffels on The BioCentury Show
0:46
The BioCentury-BayHelix East West Biopharma Summit
25:58
Ep. 247 - Drug Pricing, Psychedelic Setback & Back to School
17:18
Seeking licensing and acquisition opportunities using BCIQ
32:20
Ep. 257 - Schizophrenia, Sickle Cell Drugs, D.C. Update
33:51 39:34 7:30 35:24 26:58 32:03 31:31 0:42 0:37 34:40 21:50 34:19 1:20 2:26 0:43 0:45 0:46 25:58 17:18 32:20
